• Report Description
  • Table Of Content
  • Request Methodology

KD Market Insights added a title on “Acute Lymphoblastic Leukemia Therapeutics Market – 2019-2024” to its collection of industry research reports that offers extensive and highly detailed current and future market trends in the global and regional/market. The report includes market size, Y-O-Y growth analysis and structure of the overall industry based on a unique combination of industry research, fieldwork, market sizing analysis, and our in-house expertise.

The market research report demonstrates market dynamics which includes growth drivers, restraining factors and opportunities and trends spearheading current Drug Type and future status of this market. Our general approach is to target several individuals with specific questions that we believed would satisfy our research objective. Further, to speed up the data collection process, we employed an online survey, delivered via email. The research team analyzed the results to identify potential opportunities and risks for the market.

In addition, the report offers recent industry activities and value chain analysis for the Acute Lymphoblastic Leukemia Therapeutics Market. Moreover, Porter’s Five Forces analysis demonstrates the five forces which include buyers bargaining power, suppliers bargaining power, the threat of new entrants, the threat of substitutes, and degree of competition in Acute Lymphoblastic Leukemia Therapeutics Market. Along with figures and tables, a market attractiveness and BPS analysis has been provided for every segment in the report.

Global Acute Lymphoblastic Leukemia Therapeutics Market Size & Forecast:

Global Acute Lymphoblastic Leukemia Therapeutics market witnessed a market value of USD XX Million in 2019 and is estimated to reach USD XX million in 2024, registering a compound annual growth rate (CAGR) of XX% between 2019 and 2024. The report analyses the market by geographies i.e. North America, Europe, Asia Pacific, Latin America & Middle East & Africa. Further, the geographies are fragmented into the country and regional groupings:

- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Global Acute Lymphoblastic Leukemia Therapeutics Market Segmentation:-

The research offers a comprehensive analysis of global Acute Lymphoblastic Leukemia Therapeutics market with respect to following sub-markets:

Based on Drug Type:
- Chemotherapy Drugs
- - - Nelarabine (Arranon)
- - - Blinatumomab (Blincyto)
- - - Clofarabine (Clolar)
- - - Erwinia (Erwinase)
- - - Pegaspargase (Oncaspar)
- - - Vincristine (Marqibo)
- - - Others
- Immunotherapy Drugs
- - - Tisagenlecleucel (Kymriah)
- Targeted Therapy Drugs
- - - Imatinib (Gleevec)
- - - Dasatinib (Sprycel)
- - - Nilotinib (Tasigna)
- - - Others
- Others

Based on Indication:
- Precursor B Cell ALL
- Mature B Cell ALL
- Precursor T Cell ALL

Based on Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies

Global Acute Lymphoblastic Leukemia Therapeutics Market: Competitive Landscape

The report also highlights the competitive landscape of the global Acute Lymphoblastic Leukemia Therapeutics market, market share and positioning of all the major players in the industry. The competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as company overview, financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, Drug Type development, research & development and other market activities).

The report includes profiles of leading companies in the global Acute Lymphoblastic Leukemia Therapeutics market.

Some of the key players profiled include:

- Novartis Pharmaceuticals
- Pfizer Inc.
- Genzyme Corporation
- GlaxoSmithKline Plc.
- ERYTECH Pharma
- Talon Therapeutic, Inc.
- Sigma-Tau Pharmaceuticals, Inc.
- Spectrum Pharmaceuticals, Inc.
- F. Hoffmann-La Roche Ltd.
- Biogen Idec, Inc.
- Bristol-Myers Squibb
- Celgene Corporation
- Other Major & Niche Key Players

Timeline Considered for Analysis:

- 2015 to 2017 – Historical Year
- 2018 – Base Year
- 2019 – Estimated Year
- 2019 to 2024 – Forecasted Year

Customization: We also offers customization’s in the industry report as per the company’s specific needs.

Key Questions Answered in the Global Acute Lymphoblastic Leukemia Therapeutics Industry Report:

- What is the overall market size in 2018? What will be the market growth during the forecast period i.e. 2019-2024?
- Which region would have high demand for product in the upcoming years?
- What are the factors driving the growth of the market?
- Which sub-market will make the most significant contribution to the market?
- What are the market opportunities for existing and entry-level players?
- What are various long-term and short-term strategies adopted by the market players?

1. Preface

1.1. Research Methodology
1.1.1. Industry Research
1.1.2. Research Process and Design
1.1.2.1. Secondary Research
1.1.2.2. Key Sources and Use of Primary Research
1.1.2.3. Market Size Estimation and Forecast
1.1.2.4. Research Report
1.2. Geographic Scope
1.3. Years Considered
1.4. Key Deliverables of the Study
1.5. Assumptions and Limitations for Market Estimation and Forecasting

2. Executive Summary

2.1. Market Snapshot
2.2. Market Overview
2.3. CXO Perspective
2.4. Top Global Acute Lymphoblastic Leukemia Therapeutics Market Trends for 2019

3. Porter’s Five Force Analysis

3.1. Threat of Substitutes
3.2. Bargaining Power of Buyers
3.3. Bargaining Power of Suppliers
3.4. Threat of New Entrants
3.5. Degree of Competition

4. Manufacturing Cost Structure Analysis

4.1. Raw Material and Suppliers
4.2. Industry Chain Structure of Acute Lymphoblastic Leukemia Therapeutics
4.3. Manufacturing Process Analysis of Acute Lymphoblastic Leukemia Therapeutics
4.4. Manufacturing Cost Structure Analysis of Acute Lymphoblastic Leukemia Therapeutics

5. Manufacturing Plants Analysis of Acute Lymphoblastic Leukemia Therapeutics

5.1. Capacity and Production
5.2. Global Acute Lymphoblastic Leukemia Therapeutics Manufacturing Plants Distribution
5.3. Recent Development and Expansion Plans

6. Competitive Landscape

6.1. Global Acute Lymphoblastic Leukemia Therapeutics Market 2018
6.2. Global Acute Lymphoblastic Leukemia Therapeutics Market Value Share, By Company 2018
6.3. Global Acute Lymphoblastic Leukemia Therapeutics Market Volume Share, By Company 2018

7. Market Dynamics

7.1. Growth Drivers & Barriers in Honey Market
7.1.1. North America
7.1.2. Europe
7.1.3. Asia Pacific
7.1.4. Rest of World
7.2. Opportunities in Honey Market

8. Global Acute Lymphoblastic Leukemia Therapeutics Market

8.1. Introduction
8.2. Key Trends & Growth Drivers
8.3. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
8.4. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

9. Global Acute Lymphoblastic Leukemia Therapeutics Market Segmentation Analysis, By Drug Type

9.1. Introduction
9.2. Strategic Insights
9.2.1. BPS Analysis, By Drug Type
9.2.2. Market Attractiveness, By Drug Type
9.3. Chemotherapy Drugs
9.3.1. Nelarabine (Arranon)
9.3.1.1. Key Trends & Growth Drivers
9.3.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.2. Blinatumomab (Blincyto)
9.3.2.1. Key Trends & Growth Drivers
9.3.2.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.2.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.3. Clofarabine (Clolar)
9.3.3.1. Key Trends & Growth Drivers
9.3.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.4. Erwinia (Erwinase)
9.3.4.1. Key Trends & Growth Drivers
9.3.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.5. Pegaspargase (Oncaspar)
9.3.5.1. Key Trends & Growth Drivers
9.3.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.6. Vincristine (Marqibo)
9.3.6.1. Key Trends & Growth Drivers
9.3.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.7. Others
9.3.7.1. Key Trends & Growth Drivers
9.3.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4. Immunotherapy Drugs
9.4.1. Tisagenlecleucel (Kymriah)
9.4.1.1. Key Trends & Growth Drivers
9.4.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.5. Targeted Therapy Drugs
9.5.1. Imatinib (Gleevec)
9.5.1.1. Key Trends & Growth Drivers
9.5.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.5.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.5.2. Dasatinib (Sprycel)
9.5.2.1. Key Trends & Growth Drivers
9.5.2.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.5.2.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.5.3. Nilotinib (Tasigna)
9.5.3.1. Key Trends & Growth Drivers
9.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.5.4. Others
9.5.4.1. Key Trends & Growth Drivers
9.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.6. Others
9.6.1. Key Trends & Growth Drivers
9.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

10. Global Acute Lymphoblastic Leukemia Therapeutics Market Segmentation Analysis, By Indication

10.1. Introduction
10.2. Strategic Insights
10.2.1. BPS Analysis, By Indication
10.2.2. Market Attractiveness, By Indication
10.3. Precursor B Cell ALL
10.3.1. Key Trends & Growth Drivers
10.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10.4. Mature B Cell ALL
10.4.1. Key Trends & Growth Drivers
10.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10.5. Precursor T Cell ALL
10.5.1. Key Trends & Growth Drivers
10.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

11. Global Acute Lymphoblastic Leukemia Therapeutics Market Segmentation Analysis, By Distribution Channel

11.1. Introduction
11.2. Strategic Insights
11.2.1. BPS Analysis, By Distribution Channel
11.2.2. Market Attractiveness, By Distribution Channel
11.3. Hospitals
11.3.1. Key Trends & Growth Drivers
11.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4. Online Pharmacies
11.4.1. Key Trends & Growth Drivers
11.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5. Retail Pharmacies
11.5.1. Key Trends & Growth Drivers
11.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

12. Geographical Analysis

12.1. Introduction
12.2. North America Acute Lymphoblastic Leukemia Therapeutics Market
12.2.1. Key Trends & Growth Drivers
12.2.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4. By Drug Type
12.2.4.1. Introduction
12.2.4.2. Strategic Insights
12.2.4.2.1. BPS Analysis, By Drug Type
12.2.4.2.2. Market Attractiveness, By Drug Type
12.2.4.3. Chemotherapy Drugs
12.2.4.3.1. Nelarabine (Arranon)
12.2.4.3.1.1. Key Trends & Growth Drivers
12.2.4.3.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.3.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.3.2. Blinatumomab (Blincyto)
12.2.4.3.2.1. Key Trends & Growth Drivers
12.2.4.3.2.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.3.2.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.3.3. Clofarabine (Clolar)
12.2.4.3.3.1. Key Trends & Growth Drivers
12.2.4.3.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.3.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.3.4. Erwinia (Erwinase)
12.2.4.3.4.1. Key Trends & Growth Drivers
12.2.4.3.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.3.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.3.5. Pegaspargase (Oncaspar)
12.2.4.3.5.1. Key Trends & Growth Drivers
12.2.4.3.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.3.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.3.6. Vincristine (Marqibo)
12.2.4.3.6.1. Key Trends & Growth Drivers
12.2.4.3.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.3.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.3.7. Others
12.2.4.3.7.1. Key Trends & Growth Drivers
12.2.4.3.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.3.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.4. Immunotherapy Drugs
12.2.4.4.1. Tisagenlecleucel (Kymriah)
12.2.4.4.1.1. Key Trends & Growth Drivers
12.2.4.4.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.4.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.5. Targeted Therapy Drugs
12.2.4.5.1. Imatinib (Gleevec)
12.2.4.5.1.1. Key Trends & Growth Drivers
12.2.4.5.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.5.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.5.2. Dasatinib (Sprycel)
12.2.4.5.2.1. Key Trends & Growth Drivers
12.2.4.5.2.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.5.2.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.5.3. Nilotinib (Tasigna)
12.2.4.5.3.1. Key Trends & Growth Drivers
12.2.4.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.5.4. Others
12.2.4.5.4.1. Key Trends & Growth Drivers
12.2.4.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.6. Others
12.2.4.6.1. Key Trends & Growth Drivers
12.2.4.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.5. By Indication
12.2.5.1. Introduction
12.2.5.2. Strategic Insights
12.2.5.2.1. BPS Analysis, By Indication
12.2.5.2.2. Market Attractiveness, By Indication
12.2.5.3. Precursor B Cell ALL
12.2.5.3.1. Key Trends & Growth Drivers
12.2.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.5.4. Mature B Cell ALL
12.2.5.4.1. Key Trends & Growth Drivers
12.2.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.5.5. Precursor T Cell ALL
12.2.5.5.1. Key Trends & Growth Drivers
12.2.5.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.5.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.6. By Distribution Channel
12.2.6.1. Introduction
12.2.6.2. Strategic Insights
12.2.6.2.1. BPS Analysis, By Distribution Channel
12.2.6.2.2. Market Attractiveness, By Distribution Channel
12.2.6.3. Hospitals
12.2.6.3.1. Key Trends & Growth Drivers
12.2.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.6.4. Online Pharmacies
12.2.6.4.1. Key Trends & Growth Drivers
12.2.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.6.5. Retail Pharmacies
12.2.6.5.1. Key Trends & Growth Drivers
12.2.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.7. By Country
12.2.7.1. Introduction
12.2.7.2. Strategic Insights
12.2.7.2.1. BPS Analysis, By Country
12.2.7.2.2. Market Attractiveness, By Country
12.2.7.3. U.S. Acute Lymphoblastic Leukemia Therapeutics Market
12.2.7.3.1. Key Trends & Growth Drivers
12.2.7.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.7.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.7.4. Canada Acute Lymphoblastic Leukemia Therapeutics Market
12.2.7.4.1. Key Trends & Growth Drivers
12.2.7.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.7.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

12.3. Europe Acute Lymphoblastic Leukemia Therapeutics Market

12.3.1. Key Trends & Growth Drivers
12.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4. By Drug Type
12.3.4.1. Introduction
12.3.4.2. Strategic Insights
12.3.4.2.1. BPS Analysis, By Drug Type
12.3.4.2.2. Market Attractiveness, By Drug Type
12.3.4.3. Chemotherapy Drugs
12.3.4.3.1. Nelarabine (Arranon)
12.3.4.3.1.1. Key Trends & Growth Drivers
12.3.4.3.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.3.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.3.2. Blinatumomab (Blincyto)
12.3.4.3.2.1. Key Trends & Growth Drivers
12.3.4.3.2.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.3.2.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.3.3. Clofarabine (Clolar)
12.3.4.3.3.1. Key Trends & Growth Drivers
12.3.4.3.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.3.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.3.4. Erwinia (Erwinase)
12.3.4.3.4.1. Key Trends & Growth Drivers
12.3.4.3.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.3.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.3.5. Pegaspargase (Oncaspar)
12.3.4.3.5.1. Key Trends & Growth Drivers
12.3.4.3.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.3.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.3.6. Vincristine (Marqibo)
12.3.4.3.6.1. Key Trends & Growth Drivers
12.3.4.3.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.3.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.3.7. Others
12.3.4.3.7.1. Key Trends & Growth Drivers
12.3.4.3.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.3.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.4. Immunotherapy Drugs
12.3.4.4.1. Tisagenlecleucel (Kymriah)
12.3.4.4.1.1. Key Trends & Growth Drivers
12.3.4.4.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.4.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.5. Targeted Therapy Drugs
12.3.4.5.1. Imatinib (Gleevec)
12.3.4.5.1.1. Key Trends & Growth Drivers
12.3.4.5.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.5.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.5.2. Dasatinib (Sprycel)
12.3.4.5.2.1. Key Trends & Growth Drivers
12.3.4.5.2.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.5.2.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.5.3. Nilotinib (Tasigna)
12.3.4.5.3.1. Key Trends & Growth Drivers
12.3.4.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.5.4. Others
12.3.4.5.4.1. Key Trends & Growth Drivers
12.3.4.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.6. Others
12.3.4.6.1. Key Trends & Growth Drivers
12.3.4.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.5. By Indication
12.3.5.1. Introduction
12.3.5.2. Strategic Insights
12.3.5.2.1. BPS Analysis, By Indication
12.3.5.2.2. Market Attractiveness, By Indication
12.3.5.3. Precursor B Cell ALL
12.3.5.3.1. Key Trends & Growth Drivers
12.3.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.5.4. Mature B Cell ALL
12.3.5.4.1. Key Trends & Growth Drivers
12.3.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.5.5. Precursor T Cell ALL
12.3.5.5.1. Key Trends & Growth Drivers
12.3.5.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.5.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.6. By Distribution Channel
12.3.6.1. Introduction
12.3.6.2. Strategic Insights
12.3.6.2.1. BPS Analysis, By Distribution Channel
12.3.6.2.2. Market Attractiveness, By Distribution Channel
12.3.6.3. Hospitals
12.3.6.3.1. Key Trends & Growth Drivers
12.3.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.6.4. Online Pharmacies
12.3.6.4.1. Key Trends & Growth Drivers
12.3.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.6.5. Retail Pharmacies
12.3.6.5.1. Key Trends & Growth Drivers
12.3.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7. By Country
12.3.7.1. Introduction
12.3.7.2. Strategic Insights
12.3.7.2.1. BPS Analysis, By Country
12.3.7.2.2. Market Attractiveness, By Country
12.3.7.3. Germany Acute Lymphoblastic Leukemia Therapeutics Market
12.3.7.3.1. Key Trends & Growth Drivers
12.3.7.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.4. United Kingdom Acute Lymphoblastic Leukemia Therapeutics Market
12.3.7.4.1. Key Trends & Growth Drivers
12.3.7.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.5. France Acute Lymphoblastic Leukemia Therapeutics Market
12.3.7.5.1. Key Trends & Growth Drivers
12.3.7.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.6. Italy Acute Lymphoblastic Leukemia Therapeutics Market
12.3.7.6.1. Key Trends & Growth Drivers
12.3.7.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.7. Spain Acute Lymphoblastic Leukemia Therapeutics Market
12.3.7.7.1. Key Trends & Growth Drivers
12.3.7.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.8. Russia Acute Lymphoblastic Leukemia Therapeutics Market
12.3.7.8.1. Key Trends & Growth Drivers
12.3.7.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.9. Rest of Europe Acute Lymphoblastic Leukemia Therapeutics Market
12.3.7.9.1. Key Trends & Growth Drivers
12.3.7.9.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.9.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

12.4. Asia Pacific Acute Lymphoblastic Leukemia Therapeutics Market

12.4.1. Key Trends & Growth Drivers
12.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4. By Drug Type
12.4.4.1. Introduction
12.4.4.2. Strategic Insights
12.4.4.2.1. BPS Analysis, By Drug Type
12.4.4.2.2. Market Attractiveness, By Drug Type
12.4.4.3. Chemotherapy Drugs
12.4.4.3.1. Nelarabine (Arranon)
12.4.4.3.1.1. Key Trends & Growth Drivers
12.4.4.3.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.3.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.3.2. Blinatumomab (Blincyto)
12.4.4.3.2.1. Key Trends & Growth Drivers
12.4.4.3.2.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.3.2.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.3.3. Clofarabine (Clolar)
12.4.4.3.3.1. Key Trends & Growth Drivers
12.4.4.3.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.3.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.3.4. Erwinia (Erwinase)
12.4.4.3.4.1. Key Trends & Growth Drivers
12.4.4.3.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.3.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.3.5. Pegaspargase (Oncaspar)
12.4.4.3.5.1. Key Trends & Growth Drivers
12.4.4.3.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.3.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.3.6. Vincristine (Marqibo)
12.4.4.3.6.1. Key Trends & Growth Drivers
12.4.4.3.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.3.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.3.7. Others
12.4.4.3.7.1. Key Trends & Growth Drivers
12.4.4.3.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.3.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.4. Immunotherapy Drugs
12.4.4.4.1. Tisagenlecleucel (Kymriah)
12.4.4.4.1.1. Key Trends & Growth Drivers
12.4.4.4.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.4.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.5. Targeted Therapy Drugs
12.4.4.5.1. Imatinib (Gleevec)
12.4.4.5.1.1. Key Trends & Growth Drivers
12.4.4.5.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.5.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.5.2. Dasatinib (Sprycel)
12.4.4.5.2.1. Key Trends & Growth Drivers
12.4.4.5.2.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.5.2.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.5.3. Nilotinib (Tasigna)
12.4.4.5.3.1. Key Trends & Growth Drivers
12.4.4.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.5.4. Others
12.4.4.5.4.1. Key Trends & Growth Drivers
12.4.4.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.6. Others
12.4.4.6.1. Key Trends & Growth Drivers
12.4.4.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.5. By Indication
12.4.5.1. Introduction
12.4.5.2. Strategic Insights
12.4.5.2.1. BPS Analysis, By Indication
12.4.5.2.2. Market Attractiveness, By Indication
12.4.5.3. Precursor B Cell ALL
12.4.5.3.1. Key Trends & Growth Drivers
12.4.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.5.4. Mature B Cell ALL
12.4.5.4.1. Key Trends & Growth Drivers
12.4.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.5.5. Precursor T Cell ALL
12.4.5.5.1. Key Trends & Growth Drivers
12.4.5.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.5.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.6. By Distribution Channel
12.4.6.1. Introduction
12.4.6.2. Strategic Insights
12.4.6.2.1. BPS Analysis, By Distribution Channel
12.4.6.2.2. Market Attractiveness, By Distribution Channel
12.4.6.3. Hospitals
12.4.6.3.1. Key Trends & Growth Drivers
12.4.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.6.4. Online Pharmacies
12.4.6.4.1. Key Trends & Growth Drivers
12.4.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.6.5. Retail Pharmacies
12.4.6.5.1. Key Trends & Growth Drivers
12.4.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7. By Country
12.4.7.1. Introduction
12.4.7.2. Strategic Insights
12.4.7.2.1. BPS Analysis, By Country
12.4.7.2.2. Market Attractiveness, By Country
12.4.7.3. China Acute Lymphoblastic Leukemia Therapeutics Market
12.4.7.3.1. Key Trends & Growth Drivers
12.4.7.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.4. India Acute Lymphoblastic Leukemia Therapeutics Market
12.4.7.4.1. Key Trends & Growth Drivers
12.4.7.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.5. Japan Acute Lymphoblastic Leukemia Therapeutics Market
12.4.7.5.1. Key Trends & Growth Drivers
12.4.7.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.6. South Korea Acute Lymphoblastic Leukemia Therapeutics Market
12.4.7.6.1. Key Trends & Growth Drivers
12.4.7.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.7. Indonesia Acute Lymphoblastic Leukemia Therapeutics Market
12.4.7.7.1. Key Trends & Growth Drivers
12.4.7.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.8. Taiwan Acute Lymphoblastic Leukemia Therapeutics Market
12.4.7.8.1. Key Trends & Growth Drivers
12.4.7.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.9. Australia Acute Lymphoblastic Leukemia Therapeutics Market
12.4.7.9.1. Key Trends & Growth Drivers
12.4.7.9.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.9.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.10. New Zealand Acute Lymphoblastic Leukemia Therapeutics Market
12.4.7.10.1. Key Trends & Growth Drivers
12.4.7.10.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.10.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.11. Rest of Asia Pacific Acute Lymphoblastic Leukemia Therapeutics Market
12.4.7.11.1. Key Trends & Growth Drivers
12.4.7.11.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.11.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

12.5. Latin America Acute Lymphoblastic Leukemia Therapeutics Market

12.5.1. Key Trends & Growth Drivers
12.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4. By Drug Type
12.5.4.1. Introduction
12.5.4.2. Strategic Insights
12.5.4.2.1. BPS Analysis, By Drug Type
12.5.4.2.2. Market Attractiveness, By Drug Type
12.5.4.3. Chemotherapy Drugs
12.5.4.3.1. Nelarabine (Arranon)
12.5.4.3.1.1. Key Trends & Growth Drivers
12.5.4.3.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.3.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.3.2. Blinatumomab (Blincyto)
12.5.4.3.2.1. Key Trends & Growth Drivers
12.5.4.3.2.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.3.2.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.3.3. Clofarabine (Clolar)
12.5.4.3.3.1. Key Trends & Growth Drivers
12.5.4.3.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.3.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.3.4. Erwinia (Erwinase)
12.5.4.3.4.1. Key Trends & Growth Drivers
12.5.4.3.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.3.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.3.5. Pegaspargase (Oncaspar)
12.5.4.3.5.1. Key Trends & Growth Drivers
12.5.4.3.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.3.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.3.6. Vincristine (Marqibo)
12.5.4.3.6.1. Key Trends & Growth Drivers
12.5.4.3.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.3.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.3.7. Others
12.5.4.3.7.1. Key Trends & Growth Drivers
12.5.4.3.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.3.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.4. Immunotherapy Drugs
12.5.4.4.1. Tisagenlecleucel (Kymriah)
12.5.4.4.1.1. Key Trends & Growth Drivers
12.5.4.4.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.4.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.5. Targeted Therapy Drugs
12.5.4.5.1. Imatinib (Gleevec)
12.5.4.5.1.1. Key Trends & Growth Drivers
12.5.4.5.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.5.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.5.2. Dasatinib (Sprycel)
12.5.4.5.2.1. Key Trends & Growth Drivers
12.5.4.5.2.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.5.2.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.5.3. Nilotinib (Tasigna)
12.5.4.5.3.1. Key Trends & Growth Drivers
12.5.4.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.5.4. Others
12.5.4.5.4.1. Key Trends & Growth Drivers
12.5.4.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.6. Others
12.5.4.6.1. Key Trends & Growth Drivers
12.5.4.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.5. By Indication
12.5.5.1. Introduction
12.5.5.2. Strategic Insights
12.5.5.2.1. BPS Analysis, By Indication
12.5.5.2.2. Market Attractiveness, By Indication
12.5.5.3. Precursor B Cell ALL
12.5.5.3.1. Key Trends & Growth Drivers
12.5.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.5.4. Mature B Cell ALL
12.5.5.4.1. Key Trends & Growth Drivers
12.5.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.5.5. Precursor T Cell ALL
12.5.5.5.1. Key Trends & Growth Drivers
12.5.5.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.5.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.6. By Distribution Channel
12.5.6.1. Introduction
12.5.6.2. Strategic Insights
12.5.6.2.1. BPS Analysis, By Distribution Channel
12.5.6.2.2. Market Attractiveness, By Distribution Channel
12.5.6.3. Hospitals
12.5.6.3.1. Key Trends & Growth Drivers
12.5.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.6.4. Online Pharmacies
12.5.6.4.1. Key Trends & Growth Drivers
12.5.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.6.5. Retail Pharmacies
12.5.6.5.1. Key Trends & Growth Drivers
12.5.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.7. By Country
12.5.7.1. Introduction
12.5.7.2. Strategic Insights
12.5.7.2.1. BPS Analysis, By Country
12.5.7.2.2. Market Attractiveness, By Country
12.5.7.3. Brazil Acute Lymphoblastic Leukemia Therapeutics Market
12.5.7.3.1. Key Trends & Growth Drivers
12.5.7.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.7.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.7.4. Mexico Acute Lymphoblastic Leukemia Therapeutics Market
12.5.7.4.1. Key Trends & Growth Drivers
12.5.7.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.7.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.7.5. Rest of Latin America Acute Lymphoblastic Leukemia Therapeutics Market
12.5.7.5.1. Key Trends & Growth Drivers
12.5.7.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.7.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

12.6. Middle East & Africa Acute Lymphoblastic Leukemia Therapeutics Market

12.6.1. Key Trends & Growth Drivers
12.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4. By Drug Type
12.6.4.1. Introduction
12.6.4.2. Strategic Insights
12.6.4.2.1. BPS Analysis, By Drug Type
12.6.4.2.2. Market Attractiveness, By Drug Type
12.6.4.3. Chemotherapy Drugs
12.6.4.3.1. Nelarabine (Arranon)
12.6.4.3.1.1. Key Trends & Growth Drivers
12.6.4.3.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.3.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.3.2. Blinatumomab (Blincyto)
12.6.4.3.2.1. Key Trends & Growth Drivers
12.6.4.3.2.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.3.2.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.3.3. Clofarabine (Clolar)
12.6.4.3.3.1. Key Trends & Growth Drivers
12.6.4.3.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.3.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.3.4. Erwinia (Erwinase)
12.6.4.3.4.1. Key Trends & Growth Drivers
12.6.4.3.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.3.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.3.5. Pegaspargase (Oncaspar)
12.6.4.3.5.1. Key Trends & Growth Drivers
12.6.4.3.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.3.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.3.6. Vincristine (Marqibo)
12.6.4.3.6.1. Key Trends & Growth Drivers
12.6.4.3.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.3.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.3.7. Others
12.6.4.3.7.1. Key Trends & Growth Drivers
12.6.4.3.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.3.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.4. Immunotherapy Drugs
12.6.4.4.1. Tisagenlecleucel (Kymriah)
12.6.4.4.1.1. Key Trends & Growth Drivers
12.6.4.4.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.4.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.5. Targeted Therapy Drugs
12.6.4.5.1. Imatinib (Gleevec)
12.6.4.5.1.1. Key Trends & Growth Drivers
12.6.4.5.1.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.5.1.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.5.2. Dasatinib (Sprycel)
12.6.4.5.2.1. Key Trends & Growth Drivers
12.6.4.5.2.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.5.2.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.5.3. Nilotinib (Tasigna)
12.6.4.5.3.1. Key Trends & Growth Drivers
12.6.4.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.5.4. Others
12.6.4.5.4.1. Key Trends & Growth Drivers
12.6.4.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.6. Others
12.6.4.6.1. Key Trends & Growth Drivers
12.6.4.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.5. By Indication
12.6.5.1. Introduction
12.6.5.2. Strategic Insights
12.6.5.2.1. BPS Analysis, By Indication
12.6.5.2.2. Market Attractiveness, By Indication
12.6.5.3. Precursor B Cell ALL
12.6.5.3.1. Key Trends & Growth Drivers
12.6.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.5.4. Mature B Cell ALL
12.6.5.4.1. Key Trends & Growth Drivers
12.6.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.5.5. Precursor T Cell ALL
12.6.5.5.1. Key Trends & Growth Drivers
12.6.5.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.5.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.6. By Distribution Channel
12.6.6.1. Introduction
12.6.6.2. Strategic Insights
12.6.6.2.1. BPS Analysis, By Distribution Channel
12.6.6.2.2. Market Attractiveness, By Distribution Channel
12.6.6.3. Hospitals
12.6.6.3.1. Key Trends & Growth Drivers
12.6.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.6.4. Online Pharmacies
12.6.6.4.1. Key Trends & Growth Drivers
12.6.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.6.5. Retail Pharmacies
12.6.6.5.1. Key Trends & Growth Drivers
12.6.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7. By Geography
12.6.7.1. Introduction
12.6.7.2. Strategic Insights
12.6.7.2.1. BPS Analysis, By Geography
12.6.7.2.2. Market Attractiveness, By Geography
12.6.7.3. GCC Acute Lymphoblastic Leukemia Therapeutics Market
12.6.7.3.1. Key Trends & Growth Drivers
12.6.7.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.4. North Africa Acute Lymphoblastic Leukemia Therapeutics Market
12.6.7.4.1. Key Trends & Growth Drivers
12.6.7.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.5. South Africa Acute Lymphoblastic Leukemia Therapeutics Market
12.6.7.5.1. Key Trends & Growth Drivers
12.6.7.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.6. Rest of Middle East & Africa Acute Lymphoblastic Leukemia Therapeutics Market
12.6.7.6.1. Key Trends & Growth Drivers
12.6.7.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

13. Company Profile

13.1. Market Share of Key Players in Acute Lymphoblastic Leukemia Therapeutics Market
13.1.1. Novartis Pharmaceuticals
13.1.1.1. Company Overview
13.1.1.2. Product Offered
13.1.1.3. Business Strategy
13.1.1.4. Financials
13.1.1.5. SWOT Analysis
13.1.1.6. Market Share Analysis
13.1.1.7. Key Achievements & Developments
13.1.2. Pfizer Inc.
13.1.2.1. Company Overview
13.1.2.2. Product Offered
13.1.2.3. Business Strategy
13.1.2.4. Financials
13.1.2.5. SWOT Analysis
13.1.2.6. Market Share Analysis
13.1.2.7. Key Achievements & Developments
13.1.3. Genzyme Corporation
13.1.3.1. Company Overview
13.1.3.2. Product Offered
13.1.3.3. Business Strategy
13.1.3.4. Financials
13.1.3.5. SWOT Analysis
13.1.3.6. Market Share Analysis
13.1.3.7. Key Achievements & Developments
13.1.4. GlaxoSmithKline Plc.
13.1.4.1. Company Overview
13.1.4.2. Product Offered
13.1.4.3. Business Strategy
13.1.4.4. Financials
13.1.4.5. SWOT Analysis
13.1.4.6. Market Share Analysis
13.1.4.7. Key Achievements & Developments
13.1.5. ERYTECH Pharma
13.1.5.1. Company Overview
13.1.5.2. Product Offered
13.1.5.3. Business Strategy
13.1.5.4. Financials
13.1.5.5. SWOT Analysis
13.1.5.6. Market Share Analysis
13.1.5.7. Key Achievements & Developments
13.1.6. Talon Therapeutic, Inc.
13.1.6.1. Company Overview
13.1.6.2. Product Offered
13.1.6.3. Business Strategy
13.1.6.4. Financials
13.1.6.5. SWOT Analysis
13.1.6.6. Market Share Analysis
13.1.6.7. Key Achievements & Developments
13.1.7. Sigma-Tau Pharmaceuticals, Inc.
13.1.7.1. Company Overview
13.1.7.2. Product Offered
13.1.7.3. Business Strategy
13.1.7.4. Financials
13.1.7.5. SWOT Analysis
13.1.7.6. Market Share Analysis
13.1.7.7. Key Achievements & Developments
13.1.8. Spectrum Pharmaceuticals, Inc.
13.1.8.1. Company Overview
13.1.8.2. Product Offered
13.1.8.3. Business Strategy
13.1.8.4. Financials
13.1.8.5. SWOT Analysis
13.1.8.6. Market Share Analysis
13.1.8.7. Key Achievements & Developments
13.1.9. F. Hoffmann-La Roche Ltd.
13.1.9.1. Company Overview
13.1.9.2. Product Offered
13.1.9.3. Business Strategy
13.1.9.4. Financials
13.1.9.5. SWOT Analysis
13.1.9.6. Market Share Analysis
13.1.9.7. Key Achievements & Developments
13.1.10. Biogen Idec, Inc.
13.1.10.1. Company Overview
13.1.10.2. Product Offered
13.1.10.3. Business Strategy
13.1.10.4. Financials
13.1.10.5. SWOT Analysis
13.1.10.6. Market Share Analysis
13.1.10.7. Key Achievements & Developments
13.1.11. Bristol-Myers Squibb
13.1.11.1. Company Overview
13.1.11.2. Product Offered
13.1.11.3. Business Strategy
13.1.11.4. Financials
13.1.11.5. SWOT Analysis
13.1.11.6. Market Share Analysis
13.1.11.7. Key Achievements & Developments
13.1.12. Celgene Corporation
13.1.12.1. Company Overview
13.1.12.2. Product Offered
13.1.12.3. Business Strategy
13.1.12.4. Financials
13.1.12.5. SWOT Analysis
13.1.12.6. Market Share Analysis
13.1.12.7. Key Achievements & Developments
13.1.13. Other Prominent Players

14. Disclaimer

Select License Type
  • Single User License $3750 USD
  • Multi-User License $4750 USD
  • Corporate User License $5750 USD

Request For Customization



Request Customization

Check Discount



Request Discount

Corporate Clients

More than 200 Clients